The model reveals that low rates of GLP-1 secretion, frequently associated with T2DM and NASH, may be also be caused by splanchnic hypoglycaemia, rather than to intrinsic loss of incretin secretory capacity. The gene discussed is GCG; the disease is metabolic dysfunction-associated steatohepatitis.